30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kling Douglas F

Track

Insider profile

Kling Douglas F's trades of NewAmsterdam Pharma Company NV's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-06 2026-01-06
PrS Proposed sale
10,294
480.51
US$3,850,850 		10,294 480.51 US$3,850,850
2025-07-17 2025-07-16
PlS Planned sale
72,654 +46.7%
121.43
US$1,654,779 		72,654 +46.7% 121.43 US$1,654,779
2025-07-17 2025-07-15
PlS Planned sale
41,509 -49.9%
456.05
US$2,691,968 		41,509 -49.9% 456.05 US$2,691,968
2025-07-17 2025-07-15
PlS Planned sale
44,025 -48.1%
21.38
US$941,254 		44,025 -48.1% 21.38 US$941,254
2025-06-18 2025-06-16
PlS Planned sale
18,109 -29.2%
19.75
US$357,653 		18,109 -29.2% 19.75 US$357,653
2025-06-18 2025-06-16
PlS Planned sale
81,891 -56.9%
19.19
US$1,571,488 		81,891 -56.9% 19.19 US$1,571,488
2025-05-15 2025-05-15
PrS Proposed sale
298,612
18.75
US$5,598,975 		298,612 18.75 US$5,598,975
2025-03-26 2025-03-26
PrS Proposed sale
16,539
23.41
US$387,178 		16,539 23.41 US$387,178
2025-01-27 2025-01-27
PrS Proposed sale
500,000
23.20
US$11,600,000 		500,000 23.20 US$11,600,000